We look at how lenacapavir, a groundbreaking HIV prevention injection, is set to transform the fight against HIV and why it matters for millions worldwide.

Gilead Applauds Collaborative Efforts to Launch Lenacapavir for HIV Prevention in South Africa

The Presidency says Lenacapavir, a twice-yearly HIV prevention injection, will expand biomedical tools in South Africa’s fight against new infections and strengthen long-term…